Prothena reported $632.7M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 717.67M 6.76M
Adamas Pharmaceuticals ADMS:US 143.98M 6.67M
Agios Pharmaceuticals AGIO:US $ 1541.5M 333.1M
Akebia Therapeutics AKBA:US $ 602.27M 9.6M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
ALKERMES ALKS:US $ 1995.43M 57.86M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amgen AMGN:US $ 64993M 5220M
Biogen BIIB:US $ 23806.7M 663.7M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Exelixis EXEL:US $ 2447.74M 80.47M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
Intra Cellular Therapies ITCI:US $ 556.98M 68.72M
IONIS PHARMACEUT IONS:US $ 2415M 82.07M
Macrogenics MGNX:US $ 392.16M 33.75M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Neurocrine Biosciences NBIX:US $ 2017.3M 60.9M
Prothena PRTA:US $ 632.7M 196.33M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Seattle Genetics SGEN:US $ 3977.88M 25.72M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M
Vital Therapies VTL:US $ 156.76M 20.7M
Xoma XOMA:US $ 130.5M 5.25M
YTE INCY:US $ 4198.83M 294.21M